CD274 and lung carcinoma: Programmed death-ligand 1 (PD-L1) expression in lung cancer [15, 16] and microsatellite instability-high (MSI-H) in colorectal cancer [17] are used to predict the therapeutic effects of immune checkpoint inhibitors (ICIs).